130 related articles for article (PubMed ID: 11596159)
21. [Carbohydrate metabolic changes in cystic fibrosis].
García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
[TBL] [Abstract][Full Text] [Related]
22. Long-term benefits in lung function and nutritional status of strict metabolic control of cystic fibrosis-related diabetes.
Martín-Frías M; Máiz L; Carcavilla A; Barrio R
Arch Bronconeumol; 2011 Oct; 47(10):531-4. PubMed ID: 21798655
[TBL] [Abstract][Full Text] [Related]
23. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
Hull RL; Gibson RL; McNamara S; Deutsch GH; Fligner CL; Frevert CW; Ramsey BW; Sanda S
Diabetes Care; 2018 Apr; 41(4):823-830. PubMed ID: 29437698
[TBL] [Abstract][Full Text] [Related]
24. Long-term effect of insulin treatment in cystic fibrosis-related diabetes.
Mohan K; Israel KL; Miller H; Grainger R; Ledson MJ; Walshaw MJ
Respiration; 2008; 76(2):181-6. PubMed ID: 17960051
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
Fischman D; Nookala VK
Endocr Pract; 2008 Dec; 14(9):1169-79. PubMed ID: 19158056
[TBL] [Abstract][Full Text] [Related]
26. Clinical improvement in cystic fibrosis with early insulin treatment.
Dobson L; Hattersley AT; Tiley S; Elworthy S; Oades PJ; Sheldon CD
Arch Dis Child; 2002 Nov; 87(5):430-1. PubMed ID: 12390923
[No Abstract] [Full Text] [Related]
27. The impact of cystic fibrosis-related diabetes on health-related quality of life.
Kwong E; Desai S; Chong L; Lee K; Zheng J; Wilcox PG; Quon BS
J Cyst Fibros; 2019 Sep; 18(5):734-736. PubMed ID: 30935840
[TBL] [Abstract][Full Text] [Related]
28. Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis.
Bizzarri C; Montemitro E; Pedicelli S; Ciccone S; Majo F; Cappa M; Lucidi V
Pediatr Pulmonol; 2015 Feb; 50(2):144-9. PubMed ID: 24678051
[TBL] [Abstract][Full Text] [Related]
29. [Diabetes: new drugs?].
Codaccioni JL; Fontaine G
Sem Hop; 1976 May; 52(20):1243-5. PubMed ID: 189407
[No Abstract] [Full Text] [Related]
30. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
Moran A; Phillips J; Milla C
Diabetes Care; 2001 Oct; 24(10):1706-10. PubMed ID: 11574430
[TBL] [Abstract][Full Text] [Related]
31. Treatment with glibenclamide in maturity-onset diabetes mellitus.
Persson I; Madsen SN
Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
[No Abstract] [Full Text] [Related]
32. Diabetes in cystic fibrosis.
Bridges N
Paediatr Respir Rev; 2013 May; 14 Suppl 1():16-8. PubMed ID: 23522600
[TBL] [Abstract][Full Text] [Related]
33. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
34. Advances in the detection and management of cystic fibrosis related diabetes.
Hameed S; Jaffé A; Verge CF
Curr Opin Pediatr; 2015 Aug; 27(4):525-33. PubMed ID: 26087430
[TBL] [Abstract][Full Text] [Related]
35. Retinal screening of patients with cystic fibrosis-related diabetes in Wales -- a real eye opener.
Roberts R; Speight L; Lee J; George L; Ketchell RI; Lau D; Duckers J
J Cyst Fibros; 2015 Mar; 14(2):282-4. PubMed ID: 25224328
[TBL] [Abstract][Full Text] [Related]
36. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
[TBL] [Abstract][Full Text] [Related]
37. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.
Al-Mahdi M; Al Mutair A; Al Balwi M; Hussain K
Ann Saudi Med; 2010; 30(2):162-4. PubMed ID: 20220270
[TBL] [Abstract][Full Text] [Related]
38. Managing diabetes in cystic fibrosis.
Laguna TA; Nathan BM; Moran A
Diabetes Obes Metab; 2010 Oct; 12(10):858-64. PubMed ID: 20920037
[TBL] [Abstract][Full Text] [Related]
39. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
Marble A
Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
[No Abstract] [Full Text] [Related]
40. [Cystic fibrosis-related diabetes: a frequent co-morbidity].
Della Manna T; Setian N; Rodrigues JC
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):188-97. PubMed ID: 18438529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
